LUPPI, Fabrizio
 Distribuzione geografica
Continente #
NA - Nord America 9.366
EU - Europa 7.178
AS - Asia 3.914
SA - Sud America 574
Continente sconosciuto - Info sul continente non disponibili 171
AF - Africa 75
OC - Oceania 12
Totale 21.290
Nazione #
US - Stati Uniti d'America 9.172
IT - Italia 3.955
SG - Singapore 1.319
GB - Regno Unito 1.235
CN - Cina 913
VN - Vietnam 436
BR - Brasile 425
SE - Svezia 410
HK - Hong Kong 383
DE - Germania 311
FR - Francia 286
FI - Finlandia 217
BD - Bangladesh 213
UA - Ucraina 193
RU - Federazione Russa 187
TR - Turchia 123
NL - Olanda 118
IN - India 112
CA - Canada 107
KR - Corea 84
ID - Indonesia 64
BG - Bulgaria 63
AR - Argentina 53
MX - Messico 48
JP - Giappone 45
IQ - Iraq 43
IE - Irlanda 34
BE - Belgio 32
PL - Polonia 23
ZA - Sudafrica 23
EC - Ecuador 22
ES - Italia 21
VE - Venezuela 21
PK - Pakistan 20
AE - Emirati Arabi Uniti 16
IR - Iran 15
CO - Colombia 14
SA - Arabia Saudita 14
CL - Cile 13
LT - Lituania 12
MY - Malesia 12
NP - Nepal 12
AU - Australia 11
CH - Svizzera 11
MA - Marocco 11
PY - Paraguay 10
TW - Taiwan 10
AT - Austria 9
PH - Filippine 9
TH - Thailandia 9
TN - Tunisia 9
CR - Costa Rica 8
HR - Croazia 8
JO - Giordania 8
KE - Kenya 8
AZ - Azerbaigian 7
LV - Lettonia 7
PE - Perù 7
DK - Danimarca 6
EU - Europa 6
IL - Israele 6
LB - Libano 6
DZ - Algeria 5
KZ - Kazakistan 5
NO - Norvegia 5
PT - Portogallo 5
BO - Bolivia 4
CY - Cipro 4
DO - Repubblica Dominicana 4
JM - Giamaica 4
NI - Nicaragua 4
PR - Porto Rico 4
RO - Romania 4
RS - Serbia 4
SY - Repubblica araba siriana 4
UY - Uruguay 4
UZ - Uzbekistan 4
BZ - Belize 3
CZ - Repubblica Ceca 3
EE - Estonia 3
EG - Egitto 3
ET - Etiopia 3
SI - Slovenia 3
BH - Bahrain 2
BY - Bielorussia 2
GA - Gabon 2
GE - Georgia 2
GR - Grecia 2
HN - Honduras 2
HU - Ungheria 2
KG - Kirghizistan 2
KW - Kuwait 2
LU - Lussemburgo 2
MN - Mongolia 2
OM - Oman 2
PA - Panama 2
PS - Palestinian Territory 2
QA - Qatar 2
RE - Reunion 2
SC - Seychelles 2
Totale 21.101
Città #
Ashburn 943
Southend 887
Singapore 869
Fairfield 794
Santa Clara 779
Chandler 478
Woodbridge 476
San Jose 447
Houston 398
Hong Kong 371
Ann Arbor 308
Milan 292
Rome 286
Seattle 275
Wilmington 265
Council Bluffs 254
Jacksonville 252
Cambridge 244
Dearborn 233
Nyköping 222
Beijing 204
London 164
Helsinki 162
New York 162
Hefei 155
Modena 155
Los Angeles 139
Ho Chi Minh City 121
Hanoi 113
Chicago 107
San Diego 101
The Dalles 94
Florence 73
Naples 70
Dallas 69
Seoul 67
Shanghai 65
Columbus 63
Sofia 60
Bologna 58
Princeton 56
Buffalo 55
Izmir 55
Palermo 54
Eugene 52
Catania 48
Jakarta 47
Lauterbourg 47
Salt Lake City 47
Bari 46
São Paulo 46
Orem 44
Moscow 43
Redwood City 40
Munich 39
Turin 35
Bremen 33
Phoenix 33
Verona 33
Genoa 32
Boardman 30
Brussels 29
Montreal 29
Tokyo 29
Chennai 27
Frankfurt am Main 27
Toronto 27
Cagliari 25
Padova 25
Atlanta 24
Da Nang 22
Mexico City 21
Baghdad 20
Salerno 20
Falls Church 19
Guangzhou 19
Mountain View 19
Haiphong 18
Tampa 18
Bergamo 17
Boston 17
Pisa 17
Brescia 16
Manchester 16
Parma 16
Brooklyn 15
Des Moines 15
Reggio Emilia 15
Treviso 15
Warsaw 15
Elk Grove Village 14
Fremont 14
Turku 14
Buenos Aires 13
Cinisello Balsamo 13
Denver 13
Dublin 13
Miano 13
Mumbai 13
Dhaka 12
Totale 12.914
Nome #
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 3.885
Antibiotic treatment of severe exacerbations of chronic obstructive pulmonary disease with procalcitonin: A randomized noninferiority trial 507
Radiologic classification of usual interstitial pneumonia in rheumatoid arthritis-related interstitial lung disease: correlations with clinical, serological and demographic features of disease 489
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 447
"Velcro-type" crackles predict specific radiologic features of fibrotic interstitial lung disease 430
Analysis of pulmonary sounds for the diagnosis of interstitial lung diseases secondary to rheumatoid arthritis 421
Clusterin decreases oxidative stress in lung fibroblasts exposed to cigarette smoke 391
Detection of Pneumocystis jirovecii and Aspergillus spp. DNa in bronchoalveolar lavage fluids by commercial real-time PCr assays: comparison with conventional diagnostic tests 387
Effectiveness of pulmonary rehabilitation in patients with INTERSTITIAL LUNG DISEASE of different etiology: a multicenter prospective study 382
Levels of circulating endothelial cells are low in idiopathic pulmonary fibrosis and are further reduced by anti-fibrotic treatments 368
Structured reporting for fibrosing lung disease: a model shared by radiologist and pulmonologist 367
Morbidity and Mortality in Patients with Idiopathic Pulmonary Fibrosis Undergoing Diagnostic Surgical Lung Biopsy 367
Diagnosis of occult tuberculosis in hematological malignancy by enumeration of antigen-specific T cells. 360
NEW PERSPECTIVES IN DIAGNOSIS OF INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. VALIDATION STUDY OF AN ELECTRONIC STETHOSCOPE AND AD HOC SOFTWARE FOR DETECTION OF PULMONARY CRACKLES 357
Acute exacerbation of idiopathic pulmonary fibrosis: a clinical review 344
Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors 342
Treatment of chronic obstructive pulmonary disease and its comorbidities 338
Clinical performance of a commercial real-time PCR assay for Aspergillus DNA detection in serum samples from high-risk patients: comparison with a galactomannan enzyme immunoassay 337
Role Of The QFT-IT Assay For The Diagnosis Of Latent Tuberculosis Infection Among Adult Immigrants 329
Complex chronic co-morbidities of COPD 328
Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement 328
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 322
Pretreatment rate of decay in forced vital capacity predicts long-term response to pirfenidone in patients with idiopathic pulmonary fibrosis. 316
Prognostic role of clusterin in resected adenocarcinomas of the lung. 310
Best supportive care for idiopathic pulmonary fibrosis: Current gaps and future directions 309
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 308
Clusterin (CLU) and lung cancer 306
Interstitial pneumonia with autoimmune features: A single center prospective follow-up study 306
Prevalence Of Subclinical Liver Fibrosis Among Patients With Idiopathic Pulmonary Fibrosis 303
Acute exacerbations of chronic obstructive pulmonary disease: are antibiotics needed? 302
HRCT Patterns Of Usual Interstitial Pneumonia In Rheumatoid Lung 299
Role of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitation 296
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 296
Mindfulness-based stress reduction in patients with interstitial lung diseases: a pilot, single-centre observational study on safety and efficacy 295
Management of Idiopathic Pulmonary Fibrosis 295
Occurrence of idiopathic pulmonary fibrosis during immunosuppressive treatment: a case report 291
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 280
A Real-Life Multicenter National Study on Nintedanib in Severe Idiopathic Pulmonary Fibrosis 268
Pulmonary comorbidities associated with chronic obstructive pulmonary disease 262
INTERSTITIAL LUNG DISEASE IS ASSOCIATED TO INFECTIONS OF LOWER RESPIRATORY TRACT IN IMMUNOCOMPROMISED RHEUMATOID ARTHRITIS PATIENTS 257
Pulmonary Carcinosarcoma Arising in the Framework of an Idiopathic Pulmonary Fibrosis 255
Validation of a Method for Automatic Detection of Lung Sounds in Fibrotic Interstitial Lung Disease 254
RHEUMATOID ARTHRITIS RELATED INTERSTITIAL LUNG DISEASE. RADIOLOGICAL PATTERNS AND CORRELATIONS WITH CLINICAL, SEROLOGICAL AND DEMOGRAPHIC FEATURES OF DISEASE 253
Etiology and Level of Lung Derangement Do Not Affect the Beneficial Effect of Pulmonary Rehabilitation in Patients with Interstitial Lung Diseases 251
AB0472 PRIMARY SJOGREN SYNDROME ASSOCIATED INTERSTITIAL LUNG DISEASE: FEATURES, TREATMENT AND OUTCOME OF A MONOCENTRIC COHORT 247
Challenges in idiopathic interstitial lung disease 241
Co-trimoxazole effect on human alveolar macrophages of AIDS patients 229
High serum levels of silica nanoparticles in systemic sclerosis patients with occupational exposure: Possible pathogenetic role in disease phenotypes 212
CHARACTERIZATION OF ANTI-MPO POSITIVE INTERSTITIAL LUNG DISEASE. CLINICAL-SEROLOGIC AND RADIOLOGIC FEATURES AND SURVIVAL 210
Predictive Value of DLCO Reduction in Scleroderma Patients Without Cardio-Pulmonary Involvement at Baseline 202
Therapeutic approaches to idiopathic pulmonary fibrosis 188
Functional Progression in Patients with Interstitial Lung Disease Resulted Positive to Antisynthetase Antibodies: A Multicenter, Retrospective Analysis 171
Progression and prognosis of interstitial pneumonia with autoimmune features: a longitudinal, prospective, multi-centre study 165
Medicina personalizzata e fibrosi polmonare idiopatica 163
Interstitial lung disease and anti-myeloperoxidase antibodies: not a simple association 161
Malattie infiltrative diffuse del polmone 159
Erratum to: Prevalence and characterization of non-sicca onset primary Sjögren syndrome with interstitial lung involvement (Clinical Rheumatology, (2017), 36, 6, (1261-1268), 10.1007/s10067-017-3601-1) 142
Disease progression across the spectrum of idiopathic pulmonary fibrosis: A multicentre study 125
Pulmonary Progressive Fibrosis in Rheumatoid Arthritis and Primary Sjogren Syndrome: Similarities and Differences 124
Efectiveness of Nintedanib in Progressive Pulmonary Fibrosis Assessed by Progression Criteria: An Italian, Observational, Multicenter Study 114
Prevalence, incidence and mortality of interstitial lung disease in patients with Sjogren disease: data from the prospective observational “EMERGE” study 88
Clinical Characteristics of Anti‐Synthetase Syndrome: Analysis From the Classification Criteria for Anti‐Synthetase Syndrome Project 77
Recommendations for radiotherapy in patients with lung cancer and interstitial lung disease: A Delphi consensus process of the Italian association of radiotherapy and clinical oncology (AIRO) 60
Impact of Dosing on Functional and Clinical Outcomes of Patients With Progressive Pulmonary Fibrosis Treated With Nintedanib: Data From a Real-World, Multicentric, Italian Study 57
Multidisciplinary management of interstitial lung disease in autoimmune rheumatic diseases: an Italian Delphi consensus 17
Totale 21.290
Categoria #
all - tutte 68.977
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.977


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.256 0 0 113 107 62 92 64 84 171 100 260 203
2022/20232.122 193 178 119 181 203 237 123 198 239 112 192 147
2023/20242.061 115 139 156 199 270 224 201 225 60 95 174 203
2024/20253.315 198 112 115 263 593 432 282 211 338 136 270 365
2025/20265.719 345 191 395 599 902 443 771 254 557 519 406 337
2026/2027739 204 514 21 0 0 0 0 0 0 0 0 0
Totale 21.290